A

ACRO Biomedical Co Ltd
OTC:ACBM

Watchlist Manager
ACRO Biomedical Co Ltd
OTC:ACBM
Watchlist
Price: 0.026 USD Market Closed
Market Cap: $1.6m

Dividends

ACRO Biomedical Co Ltd
does not pay dividends

Shareholder Yield

Current shareholder yield for ACBM is hidden .

Shareholder Yield
LOCKED
Unlock
What is shareholder yield?
Dividend Yield
No dividends
Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Price Appreciation

ACBM Price
ACRO Biomedical Co Ltd

Annual Price Range
0.026
52w Low
0.0007
52w High
0.026
Price Metrics
Average Annual Return -49.67%
Standard Deviation of Annual Returns 56.35%
Max Drawdown -100%
Shares Statistics
Market Capitalization 1.6m USD
Shares Outstanding 60 040 000
Percentage of Shares Shorted
N/A

ACBM Return Decomposition
Main factors of price return

Stock Splits

ACBM's latest stock split occurred on May 22, 2017

The company executed a 3-for-1 stock split, meaning that for every share held, investors received 3 new shares.

The adjusted shares began trading on May 22, 2017. This was the only stock split in ACBM's history.

Pre-Split Price
N/A
Post-Split Price
2.5
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett